Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$34.5 - $42.19 $41,089 - $50,248
-1,191 Reduced 44.81%
1,467 $61,000
Q1 2023

May 11, 2023

BUY
$33.32 - $40.98 $88,564 - $108,924
2,658 New
2,658 $94,000
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $22,413 - $38,145
482 New
482 $22,000
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $22,413 - $38,145
482 New
482 $22,000
Q1 2022

May 12, 2022

SELL
$74.15 - $99.36 $212,958 - $285,361
-2,872 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$86.01 - $102.89 $174,944 - $209,278
2,034 Added 242.72%
2,872 $294,000
Q2 2021

Aug 11, 2021

SELL
$76.44 - $89.57 $5.22 Million - $6.11 Million
-68,238 Reduced 98.79%
838 $75,000
Q1 2021

May 11, 2021

SELL
$67.36 - $80.76 $19.4 Million - $23.3 Million
-288,125 Reduced 80.66%
69,076 $5.24 Million
Q4 2020

Feb 11, 2021

SELL
$53.08 - $69.86 $1.76 Million - $2.31 Million
-33,097 Reduced 8.48%
357,201 $24.3 Million
Q3 2020

Nov 09, 2020

BUY
$51.29 - $65.09 $265,579 - $337,036
5,178 Added 1.34%
390,298 $20.7 Million
Q2 2020

Aug 12, 2020

SELL
$34.32 - $62.43 $63,697 - $115,870
-1,856 Reduced 0.48%
385,120 $22.4 Million
Q1 2020

May 11, 2020

BUY
$32.64 - $73.63 $351,141 - $792,111
10,758 Added 2.86%
386,976 $15.3 Million
Q4 2019

Feb 06, 2020

BUY
$48.0 - $59.55 $3.55 Million - $4.41 Million
74,036 Added 24.5%
376,218 $22.4 Million
Q3 2019

Nov 07, 2019

BUY
$46.64 - $55.39 $2.18 Million - $2.59 Million
46,743 Added 18.3%
302,182 $16.1 Million
Q2 2019

Aug 08, 2019

BUY
$40.81 - $52.42 $6.08 Million - $7.8 Million
148,871 Added 139.7%
255,439 $13 Million
Q1 2019

May 09, 2019

BUY
$36.91 - $55.7 $3.93 Million - $5.93 Million
106,438 Added 81875.38%
106,568 $5.52 Million
Q1 2018

Apr 12, 2018

BUY
$31.7 - $44.1 $4,121 - $5,733
130 New
130 $5,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.